↓ Skip to main content

Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment

Overview of attention for article published in JAMA Network Open, October 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

news
3 news outlets
policy
1 policy source
twitter
15 X users
facebook
1 Facebook page

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment
Published in
JAMA Network Open, October 2021
DOI 10.1001/jamanetworkopen.2021.30587
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Master 4 8%
Researcher 4 8%
Other 3 6%
Student > Ph. D. Student 3 6%
Student > Bachelor 2 4%
Other 3 6%
Unknown 29 60%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 13 27%
Nursing and Health Professions 3 6%
Sports and Recreations 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Business, Management and Accounting 1 2%
Other 0 0%
Unknown 28 58%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 November 2023.
All research outputs
#1,586,725
of 34,306,620 outputs
Outputs from JAMA Network Open
#7,318
of 15,459 outputs
Outputs of similar age
#29,176
of 472,659 outputs
Outputs of similar age from JAMA Network Open
#270
of 512 outputs
Altmetric has tracked 34,306,620 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 15,459 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 114.1. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 472,659 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 512 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.